6533b85efe1ef96bd12bf46d

RESEARCH PRODUCT

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Guillermo SanzGuillermo SanzGuillermo SanzMariam IbáñezMariam IbáñezMariam IbáñezEsperanza SuchEsperanza SuchEsperanza Such

subject

0301 basic medicineSíndromes mielodisplásicos - Aspectos moleculares.Clinical Decision-MakingMEDLINEComputational biologyDNA sequencing03 medical and health sciences0302 clinical medicineText miningHumansMedicineGenetic Predisposition to DiseaseSangre - Células - Aspectos moleculares.Molecular Targeted TherapyGenes.Genetic Association StudiesBlood cells - Molecular aspects.business.industryDecision TreesDisease ManagementHigh-Throughput Nucleotide SequencingGenomicsHematologyPrognosisCombined Modality TherapyMyelodysplastic syndrome - Molecular aspects.030104 developmental biologyMyelodysplastic Syndromes030220 oncology & carcinogenesisMutationPoint-CounterpointMolecular biology.Biología molecular.businessBiomarkers

description

Este artículo se encuentra disponible en la siguiente URL: https://ashpublications.org/bloodadvances/article/3/21/3454/422749/Do-next-generation-sequencing-results-drive

yearjournalcountryeditionlanguage
2019-11-12Blood Advances
https://doi.org/10.1182/bloodadvances.2018022434